The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded a single-award Indefinite Delivery Contract (IDC) to Brigham & Women's Hospital Inc., a major academic medical center and research institution. The 5-year IDC, valued at a ceiling of $1,604,165, is for the provision of effectiveness research with real world data to support the Food and Drug Administration's (FDA) regulatory decision making. This "Real World Evidence Demonstration Project" allows the VA to efficiently procure specialized genomic research services from Brigham & Women's Hospital to support the VA's precision medicine initiatives for veterans' healthcare.
Under this IDC, the VA has issued at least one $279,572 firm-fixed-price delivery order to Brigham & Women's Hospital for genomic medicine research expertise. As a subsidiary of the larger Partners Healthcare System, Brigham & Women's Hospital has extensive experience conducting cutting-edge biomedical and clinical research across various medical specialties with funding from federal contracts and grants. This IDC does not appear to have any small business set-aside designations.
Generated 12/31/24, 2:03 PM